Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohort
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
BACKGROUND
Alzheimer’s disease-related biomarkers detect pathology years before symptoms emerge, when disease-modifying therapies might be most beneficial. Remote cognitive testing provides a means of assessing early changes. We explored the relationship between neurodegenerative biomarkers and cognition in cognitively normal individuals.
METHODS
We remotely deployed 13 computerised Cognitron tasks in 255 Insight 46 participants. We generated whole brain, hippocampal, and white matter hyperintensity volumes at ages 69-71, rates of change over two-years, amyloid load and positivity. We examined the relationship between Cognitron, biomarkers, and standard neuropsychological tests.
RESULTS
Slower response time on a delayed recognition task predicted amyloid positivity (OR=1.79,CI:1.15, 2.95). Brain and hippocampal atrophy rates correlated with poorer visuospatial performance ( b =-0.42, CI:-0.80, -0.05) and accuracy on immediate recognition ( b =-0.01, CI:-0.01, -0.001), respectively. Standard tests correlated with Cognitron composites (rho=0.43, p<0.001).
DISCUSSION
Remote computerised testing correlates with standard supervised assessments and holds potential for studying early cognitive changes associated with neurodegeneration.
